Dallas, TX -- (ReleaseWire) -- 07/15/2008 -- TwinTrader.com announces the publication of Breakout for AMRI; highlighting public companies on the move and what’s behind the surge.
Investors can view all of the Breakouts and other articles for free by visiting:
http://www.TwinTrader.com
“Albany Molecular Research Inc. provides contract services to various pharmaceutical and biotechnology companies in the United States and internationally. The company offers drug discovery services, including assay development and design; screening programs, which provide tools to identify active compounds during the lead finding phases of drug discovery; libraries for screening and hit-to-lead programs; bioanalytical services for extraction and quantitation of drug and metabolites in biological fluids and tissues; and natural product services…
“Albany Medical Center has announced that research into a cure for Alzheimer’s disease will take place at the new biomedical research facility at the University at Albany’s East Campus…
“As can be shown on the daily chart, Albany Molecular Research’s stock is extremely volatile. Traders have been very active in this stock as price swings of more than 30% in a week occasionally occur. After bottoming in mid-February, the RSI has looked very strong and given traders a benchmark from where to trade...”
To read the entire article visit http://www.TwinTrader.com
Join the fastest growing investor community at:
http://www.stockhideout.com
TwinTrader LLC (TT) is not a registered broker-dealer and is not a registered investment advisor. No investor should base their investments decisions upon any act or omission of TT. TT makes no representations or warranties, and none may be relied upon. The purchase and sale of any securities must be made solely with the assistance of a registered broker-dealer and/or investment advisor. TT may, and you should assume that TT does, own shares in the companies profiled on this site. TT intends to sell its shares at times and as otherwise allowed by the securities laws which may negatively affect the performance of the stock price. TT affiliates, officers, directors and employees may have also bought or may buy shares in the companies profiled on this site and may sell, and profit from the sale of, such shares at any time. Except as required by the securities laws, TT will not advise when it or its affiliates, officers, directors and employees intend to sell and will not offer any opinion as to when others should sell. Any recent increase in volume or increase in stock price may be due to trading by TT or its affiliates, officers, directors and employees. TT will not be responsible for any gains or losses due to investing based on any opinions contained on this site. Receipt of the stock profiles, either via e-mail or directly from this site, is not in any way a solicitation or recommendation to buy or sell and should be used for information purposes only. Short-term trading can be extremely risky. As with any investment decision, careful research should be done before making any decision to invest.